NCT05968014

Brief Summary

Patients were randomly divided into two groups to receive either ultrasound-guided pericapsular nerve group block (PENG group) or fascia iliaca compartment block (FICB group), using 20 ml of 0.2% ropivacaine

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2022

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

July 11, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 1, 2023

Completed
Last Updated

March 5, 2024

Status Verified

July 1, 2023

Enrollment Period

6 months

First QC Date

July 11, 2023

Last Update Submit

March 2, 2024

Conditions

Keywords

hip fracture surgeryPENG blockfascia iliaca compartment blockquality of recovery

Outcome Measures

Primary Outcomes (1)

  • The Quality of Recovery-15 scores at 24 hours postoperatively.

    Change in Quality of Recovery-15 (QoR-15) scores before and 24 hours after surgery. The QoR-15 score consists of 15 items, and includes five dimensions: pain (two items), physical confort (five items), physical independance (two items), psychological support (two items) and emotional state (four items). Each item's score ranged from 0 to 10, and the total score ranged from 0 to 150, with a higher QoR-15 score indicating a better quality of recovery.

    before and 24 hours after surgery

Secondary Outcomes (2)

  • The strength of the quadriceps

    24 hours after surgery

  • Visual analogue scale

    24 hours after surgery

Study Arms (2)

PENG block

EXPERIMENTAL

Participants enrolled in this group received a pericapsular nerve group block with 20 ml of 0.2% ropivacaine. The block was performed with a 100 mm needle, inserted with an in-plane lateral to medial approach. Operator used a low frequency curvilinear probe.

Procedure: PENG vs FICB

FIC block

EXPERIMENTAL

Patients allocated in this group received a fascia iliaca compartment block with 20 mL of 0.2% ropivacaine, using a 50 mm needle inserted with an in-plane approach. Operator used a linear probe.

Procedure: PENG vs FICB

Interventions

PENG vs FICBPROCEDURE

pericapsular nerve group block versus fascia iliaca compartment block

FIC blockPENG block

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • patients aged above 65 years
  • patients with an american society of anesthesiologists physical status I to III
  • patients undergoing hip fracture surgical repair

You may not qualify if:

  • patients with an american society of anesthesiologists physical status IV or more
  • inability or refusal to sign informed consent
  • contraindications for regional nerve block or spinal anesthesia
  • impaired cognition or dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nabeul hospital, Mohamed Taher Maamouri

Nabeul, Mrezga, 8000, Tunisia

Location

Study Officials

  • Chaima Debabi

    University Tunis El Manar

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: randomised-controlled trial with two parallel study groups. Participants will be randomised 1:1 to the PENG group or FICB group. The PENG group was treated with PENG block following randomisation, whereas the FICB group received a fascia iliaca compartment block.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 11, 2023

First Posted

August 1, 2023

Study Start

February 1, 2022

Primary Completion

July 31, 2022

Study Completion

July 31, 2022

Last Updated

March 5, 2024

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations